Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Research & Development: 2018-2022

Historic Research & Development for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$187,898.

  • ADC Therapeutics' Research & Development rose 164.98% to $27.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $18.9 million, marking a year-over-year increase of 113.57%. This contributed to the annual value of -$187,898 for FY2022, which is 18.92% down from last year.
  • As of FY2022, ADC Therapeutics' Research & Development stood at -$187,898, which was down 18.92% from -$158,002 recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Research & Development peaked at -$107,537 during FY2019, and registered a low of -$187,898 during FY2022.
  • Its 3-year average for Research & Development is -$162,644, with a median of -$158,002 in 2021.
  • As far as peak fluctuations go, ADC Therapeutics' Research & Development grew by 9.11% in 2019, and later crashed by 32.08% in 2020.
  • Over the past 5 years, ADC Therapeutics' Research & Development (Yearly) stood at -$118,313 in 2018, then climbed by 9.11% to -$107,537 in 2019, then crashed by 32.08% to -$142,032 in 2020, then declined by 11.24% to -$158,002 in 2021, then fell by 18.92% to -$187,898 in 2022.